Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Scopus BioPharma Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 21 | 1 | 19 | −1 |
| Shares | 2.88M | 1.00K | 1.01M | −1.87M (−65.0%) |
| Value | $4.71M | $2.00K | $693.0K | −$4.02M (−85.3%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Scopus BioPharma Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| M&R Capital Management Inc | 76,819 | $53.0K | 0.01% |
| Susquehanna International Group, LLP | 20,723 | $14.0K | 0.00% |
| Moors & Cabot, Inc. | 14,500 | $10.0K | 0.00% |
Sold out (4)
Institutions that held Scopus BioPharma Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Armistice Capital, LLC | 2,100,000 | $3.43M |
| Two Sigma Investments, LP | 30,403 | $50.0K |
| Millennium Management LLC | 27,043 | $44.0K |
| Citadel Advisors LLC | 20,897 | $34.0K |
Not filed for Q1 2022 yet (1)
Institutions that held Scopus BioPharma Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Harbour Investments, Inc. | 1,000 | $2.00K |